BioNeutral Retains DC-Based Law Firm Hogan & Hartson to Manage Its EPA/FDA Regulatory Process

BioNeutral Group, Inc. on September 3 reported that it has retained Hogan and Hartson, one of Washington's oldest law firms, to manage its regulatory affairs as it proceeds through the approval process for its technology.

Patrick Raher, a senior partner and the chairman of Hogan & Hartson's environmental practice, will serve as lead counsel for the BioNeutral Group.

BioNeutral is a publicly traded specialty life science company that is developing several product lines intended to neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses and spores. Some of its product applications (hard and soft surface sterilants and disinfectancts) will require certification by the Environmental Protection Agency (EPA); others (wound care, acne, sterilization of medical/surgical/dental instruments) will require approval by the Food and Drug Administration (FDA). Other product applications in the pipeline, such as stain removers, cleaners, and rust inhibitors are not regulated. Hogan & Hartson has decades of experience in helping clients achieve efficient certification and approvals in the Federal and state regulatory process.

With more than 1,100 lawyers practicing in 27 offices worldwide, Hogan & Hartson brings multiple practices and offices to bear to provide its clients with exceptional service and creative advice. Working at the intersection of business and government, both domestically and internationally, the firm helps its clients structure and complete their projects and transactions and guides them through the maze of government regulation. The firm also has special expertise in securing, protecting, and defending their clients' intellectual property.

"I have great confidence in Mr. Raher's and his team's professional ability," said Dr. Jeffrey Runge of Washington's Chertoff Group and BioNeutral's senior medical advisor. "As the former head of the National Highway Traffic Safety Administration, I had the opportunity to witness his firm's ability from the perspective of a Federal regulator. They have the highest integrity and clearly understand the regulatory process."

"We are extremely pleased to have this highly experienced and prestigious law firm join our group of platinum advisors to assist us in navigating the complexities of the regulatory process. This move will consolidate our various product registrations and is a key component to our overall business strategy," stated Stephen J. Browand, President & CEO of BioNeutral.

Headquartered at the New Jersey Institute of Technology/EDC in Newark, New Jersey, BioNeutral Group, Inc., is a chemical technology-based Life Science company that intends to commercialize a combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. The formulations, including Ygiene and Ogiene, which are eco-friendly and include natural and common ingredients found in baby products and in every day foods. The Company has combined these widely-used compounds in highly specialized ways to create products that dramatically enhance disinfecting and cleaning results; products include BioNeutralizers and ChemoNeutralizers.

((Comments on this story may be sent to newsdesk@closeupmedia.com))

Related terms: advisor, business, ceo, district of columbia, epa, fda, federal, government, law, medical, new jersey, president, products, property, technology, traffic, washington